Silver Lining: Pandemic Science Drives Approaches to Decentralized Trials for Patients – MedCity News
During the onset of the Covid-19 pandemic, the volume of new clinical trials for cancer therapies has plummeted 60 percent from January to May 2020. This statistic only adds to…